Organization

Shanghai Municipal Center for Disease Control and Prevention

1 clinical trial

Clinical trial

Immunogenicity and Safety of an Inactivated SARS-CoV-2 Vaccine Coadministered With Varicella Vaccine and Measles, Mumps and Rubella Combined Vaccine in Shanghai, China: A Non-inferiority, Open-label, Randomised, Controlled, Phase 4 Trial

Status: Not yet recruiting, Estimated PCD: 2023-12-01